Antela López Antonio
Unidad de VIH-Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Clínico Universitario de Santiago de Compostela, La Coruña, España.
Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:49-54. doi: 10.1016/S0213-005X(08)76621-7.
ART (antiretroviral therapy) currently continues to indefinitely prolong the survival of patients who live with HIV. Due to this, we are increasingly faced with specific problems that previously did not have time to develop or did not have the importance that they have now, and which are related to the existence of special patient populations. Examples of situations that characterise these special populations are: co-infection with hepatitis virus B and/or C, pregnancy, lipodystrophy, cardiovascular risk, renal failure, treatment of children and adolescents, immigrant health care, and the management of patients receiving methadone replacement therapy, among others. In this article we review the role that Atazanavir (ATV) can play in the ART of patients in the situations mentioned, except those that are already dealt with specifically in other articles, such as co-infection by hepatitis virus B and/or C.
抗逆转录病毒疗法（ART）目前仍在无限期延长艾滋病毒感染者的生存期。正因如此，我们越来越多地面临一些以前没有时间发展或没有现在这么重要的特定问题，这些问题与特殊患者群体的存在有关。这些特殊人群的典型情况包括：乙型和/或丙型肝炎病毒合并感染、妊娠、脂肪代谢障碍、心血管风险、肾衰竭、儿童和青少年治疗、移民医疗保健以及接受美沙酮替代疗法患者的管理等。在本文中，我们将回顾阿扎那韦（ATV）在上述情况患者的抗逆转录病毒治疗中所能发挥的作用，但不包括其他文章中已专门论述的情况，如乙型和/或丙型肝炎病毒合并感染。
